| Serial Number | 79381287 |
| Word Mark | MAB3 |
| Filing Date | Thursday, September 14, 2023 |
| Status | 680 - APPROVED FOR PUBLICATION |
| Status Date | Thursday, November 21, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
| Description of Mark | The mark consists of an initial lowercase letter "M" followed by an uppercase letter "A" followed by a lowercase letter "B" with a superscript numeral "3" following the lowercase letter "B". |
| Goods and Services | Pharmaceutical, biopharmaceutical and medical preparations, agents and substances, namely, preparations, agents and substances all containing or being monoclonal antibodies for medical purposes for treatment of cancer, oncological diseases and disorders, infectious diseases and disorders, inflammation and diseases, disorders and conditions associated with inflammation, inflammatory diseases and disorders, and neurological diseases and disorders; immunoglobulins being monoclonal antibodies, monoclonal antibodies, and fragments thereof, for medical use; products in the nature of pharmaceutical preparations and medicines containing immunoglobulins being monoclonal antibodies, monoclonal antibodies, and fragments thereof, for use in medicine |
| Pseudo Mark | M A B THREE |
| Goods and Services | Biological preparations for scientific, industrial, and research use; immunoglobulins being monoclonal antibodies, monoclonal antibodies, and fragments thereof, for scientific, industrial, and research use |
| Goods and Services | Scientific and technological services, namely, scientific research and design in the field of monoclonal antibodies for medical purposes; scientific research, namely, industrial analysis and research services in the field of monoclonal antibodies for medical purposes; pharmaceutical, medical, scientific and biopharmaceutical research and development in the field of monoclonal antibodies for medical purposes; drug discovery services; research relating to medicines; research and development of medicines; development of pharmaceutical and biopharmaceutical preparations and medicines |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, October 25, 2023 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, October 25, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, October 25, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | INVOX PHARMA LIMITED |
| Party Type | 11 - New Owner Before Publication |
| Legal Entity Type | 98 - Unknown |
| Address | GB |
| Party Name | F-star Therapeutics Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | GB |
| Event Date | Event Description |
| Thursday, October 19, 2023 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Wednesday, October 25, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, October 31, 2023 | APPLICATION FILING RECEIPT MAILED |
| Wednesday, May 8, 2024 | ASSIGNED TO EXAMINER |
| Tuesday, May 14, 2024 | NON-FINAL ACTION WRITTEN |
| Wednesday, May 15, 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Friday, May 24, 2024 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Friday, May 24, 2024 | REFUSAL PROCESSED BY MPU |
| Monday, June 17, 2024 | REFUSAL PROCESSED BY IB |
| Wednesday, November 20, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, November 20, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, November 20, 2024 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Wednesday, November 20, 2024 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| Wednesday, November 20, 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Wednesday, November 20, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, November 20, 2024 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Wednesday, November 20, 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Wednesday, November 20, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, November 21, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, November 21, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, November 21, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, November 21, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, November 22, 2024 | CHANGE OF OWNER RECEIVED FROM IB |